Your browser doesn't support javascript.
loading
The iCannTookit: a consensus-based, flexible framework for measuring contemporary cannabis use.
Lorenzetti, Valentina; Hindocha, Chandni; Petrilli, Kat; Griffiths, Paul; Brown, Jamie; Castillo-Carniglia, Álvaro; Caulkins, Jonathan P; Englund, Amir; El Sohly, Mahmoud A; Gage, Suzanne H; Groshkova, Teodora; Gual, Antoni; Hammond, David; Lawn, Will; López-Pelayo, Hugo; Manthey, Jakob; Mokrysz, Claire; Liccardo Pacula, Rosalie; van Laar, Margriet; Vandrey, Ryan; Wadsworth, Elle; Winstock, Adam; Hall, Wayne; Curran, H Valerie; Freeman, Tom P.
Afiliação
  • Lorenzetti V; Neuroscience of Addiction and Mental Health Program, the Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health, Australian Catholic University, Melbourne, Australia.
  • Hindocha C; Clinical Psychopharmacology Unit, University College London, London, UK.
  • Petrilli K; Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.
  • Griffiths P; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal.
  • Brown J; Behavioural Science and Health Institute of Epidemiology and Health, University College London, London, UK.
  • Castillo-Carniglia Á; Society and Health Research Center and School of Public Health, Universidad Mayor, Chile.
  • Caulkins JP; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
  • Englund A; Carnegie Mellon University Heinz College, Pittsburgh, PA, USA.
  • El Sohly MA; Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Gage SH; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Groshkova T; National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, USA.
  • Gual A; Department Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, University, MS, USA.
  • Hammond D; Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
  • Lawn W; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal.
  • López-Pelayo H; Psychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, RTA, Barcelona, Spain.
  • Manthey J; School of Public Health Sciences, University of Waterloo, Waterloo, ON, Canada.
  • Mokrysz C; Clinical Psychopharmacology Unit, University College London, London, UK.
  • Liccardo Pacula R; Psychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, RTA, Barcelona, Spain.
  • van Laar M; Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.
  • Vandrey R; Center for Interdisciplinary Addiction Research, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wadsworth E; Clinical Psychopharmacology Unit, University College London, London, UK.
  • Winstock A; USC Sol Price School of Public Policy, USC Leonard D. Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA.
  • Hall W; Trimbos Institute, Utrecht, the Netherlands.
  • Curran HV; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Freeman TP; School of Public Health Sciences, University of Waterloo, Waterloo, ON, Canada.
Addiction ; 117(9): 2558-2560, 2022 09.
Article em En | MEDLINE | ID: mdl-35603918
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cannabis / Alucinógenos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cannabis / Alucinógenos Idioma: En Ano de publicação: 2022 Tipo de documento: Article